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Abstract
Background:  Early detection of infants with permanent hearing loss through infant hearing
screening is recognised and routinely offered as a vital component of early childhood care in
developed countries. This article investigates the initiatives and progress towards early detection
of infants with hearing loss in developing countries against the backdrop of the dearth of
epidemiological data from this region.
Methods: A cross-sectional, descriptive study based on responses to a structured questionnaire
eliciting information on the nature and scope of early hearing detection services; strategies for
financing services; parental and professional attitudes towards screening; and the performance of
screening programmes. Responses were complemented with relevant data from the internet and
PubMed/Medline.
Results:  Pilot projects using objective screening tests are on-going in a growing number of
countries. Screening services are provided at public/private hospitals and/or community health
centres and at no charge only in a few countries. Attitudes amongst parents and health care
workers are typically positive towards such programmes. Screening efficiency, as measured by
referral rate at discharge, was generally found to be lower than desired but several programmes
achieved other international benchmarks. Coverage is generally above 90% but poor follow-up
rates remain a challenge in some countries. The mean age of diagnosis is usually less than six
months, even for community-based programmes.
Conclusion:  Lack of adequate resources by many governments may limit rapid nationwide
introduction of services for early hearing detection and intervention, but may not deter such
Published: 31 January 2007
BMC Health Services Research 2007, 7:14 doi:10.1186/1472-6963-7-14
Received: 26 September 2006
Accepted: 31 January 2007
This article is available from: http://www.biomedcentral.com/1472-6963/7/14
© 2007 Olusanya et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Health Services Research 2007, 7:14 http://www.biomedcentral.com/1472-6963/7/14
Page 2 of 15
(page number not for citation purposes)
services altogether. Parents may be required to pay for services in some settings in line with the
existing practice where healthcare services are predominantly financed by out-of-pocket spending
rather than public funding. However, governments and their international development partners
need to complement current voluntary initiatives through systematic scaling-up of public awareness
and requisite manpower development towards sustainable service capacities at all levels of
healthcare delivery.
Background
Chronic and non-communicable diseases have attracted
growing attention lately due predominantly to their asso-
ciated fatality which was estimated as 35 million deaths in
2005 [1]. This figure is twice the number of deaths from
all infectious diseases (including HIV/AIDS, tuberculosis
and malaria), maternal and perinatal conditions, and
nutritional deficiencies combined. Non-communicable
diseases are also associated with life-long disabilities
which are rarely addressed except through an attempt to
describe the associated burden of disease in terms of disa-
bility-adjusted life years (DALYs) or similar population
health metrics to make them comparable to all other dis-
eases [2]. This approach is an important consideration in
the Disease Control Priorities Project for developing
countries [3]. While the appropriateness of DALYs in
regions with poor data has been debated [4], chronic and
life-long conditions of childhood onset such as perma-
nent hearing impairment were excluded from this report
which may under-represent its public health significance
and current initiatives to address this problem.
Permanent disabling hearing impairment (>40 dBHL) is a
significant contributor to the global burden of disease on
individuals, families, communities and countries, affect-
ing about 250 million people worldwide as at 2005 [1].
The prevalence of disabling hearing impairment was 120
million in 1995 when the World Health Assembly (WHA)
passed a resolution on the Prevention of Hearing Impair-
ment urging member states to "prepare national plans for
the prevention and control of major causes of avoidable hearing
loss, and for early detection in babies, toddlers and children, as
well as in the elderly, within the framework of primary health
care" [5]. This estimate has more than doubled in a decade
with two-thirds of those with hearing impairment living
in developing countries and about 25% are of early child-
hood onset [1]. Permanent hearing impairment is an aeti-
ologically heterogeneous trait attributable to genetic and
environmental causes. Among the environmental causes
are infectious diseases that account for substantial infant
mortality in developing countries and which are currently
addressed through various global health programmes by
UN agencies and their development partners [6,7]. How-
ever, a significant proportion of hearing impairment is
not preventable. Moreover, the exclusion of childhood
hearing impairment in current global health priorities
may further delay the implementation of the WHA resolu-
tion in many countries where national health policies are
tailored to reflect on-going global health initiatives which
unfortunately are not yet geared towards early childhood
development.
Of all sensory disabilities in early childhood permanent
hearing impairment that originates from birth or in the
neonatal period is of special interest because of its adverse
consequences on speech, language, cognitive and psycho-
social development and the subsequent impact on educa-
tional and vocational attainment when detected late
particularly in developing countries [8]. Detection and
intervention within the first year of life is crucial for and
often associated with favourable developmental out-
comes [9-11]. Primary prevention through immunisation,
health education, improved maternal and child health
services are useful for addressing environmental causes
but limited in dealing with the full spectrum of neonatal
hearing loss attributable to genetic or hereditary aetiolo-
gies [6,7]. Screening of newborns or infants before the age
of three months has emerged within the last decade as an
effective secondary prevention strategy for the early detec-
tion of disabling permanent hearing impairment. The
development and availability of objective hearing tests
using otoacoustic emissions (OAE) and/or auditory brain-
stem response (ABR) which are suitable for testing babies
from birth has been a major impetus for this trend. These
screening tests are often automated, reliable, non-invasive
and simple-to-use by primary healthcare workers.
Although universal or selective screening of newborns is
widely implemented in developed countries, its introduc-
tion in the developing world may be constrained by reser-
vations concerning the necessity of such a programme
because of prevailing adverse health and socio-economic
conditions. For instance, the general principles for screen-
ing programmes first stated by Wilson and Jungner in
1968 [12] are often misinterpreted to suggest that an
infant hearing screening programme should not be imple-
mented until adequate follow-up services are available to
cater for children detected with hearing loss [13,14]. How-
ever,  it is difficult to justify such a requirement for prelin-
gual hearing loss which will inevitably become manifest
even without screening and for which optimum interven-
tion is time-bound  [9-11]. In fact, it is not uncommon in
traditional communities for parents to resort to unortho-BMC Health Services Research 2007, 7:14 http://www.biomedcentral.com/1472-6963/7/14
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dox and harmful therapeutic treatments for the unusual
behavioural manifestations of hearing loss during the
period of uncertainty [15-17].
The healthcare systems in many developing countries are
fragile and government funding is uncertain due to com-
peting demands from diseases with high mortality rates
such as tuberculosis, HIV/AIDS and malaria. However,
there is currently no intervention for any disease or health
condition in the developing world with adequate services
to meet the requirements for all those in need. This has led
to the concept of "scaling up" which requires the system-
atic development and expansion of intervention services
to progressively address established healthcare needs [18-
20]. Ideally, health needs are best established through
sound population-based epidemiological data. However,
such data are often lacking and difficult to obtain espe-
cially for non-life threatening conditions in developing
countries [21-23]. Rather, pilot studies have been valuable
for demonstrating the feasibility of planned programmes,
establishing service needs and for identifying potential
challenges [24]. This strategy has also been successfully
applied for the introduction of universal newborn hearing
screening in many developed countries [25-28].
Recently, Morton & Nance aptly observed that newborn
hearing screening is "a silent (global) revolution" which is
"an achievable and important goal for all nations" [29].
Reports are already emerging from a growing number of
developing countries that have voluntarily implemented
pilot programmes or projects on early hearing detection
[30], but lessons from these efforts have not yet been doc-
umented to provide relevant baseline data to facilitate glo-
bal initiatives towards systematic capacity-building for
requisite services. This cross-country study therefore set
out to examine the progress achieved so far in developing
countries in relation to current screening strategies, the
funding mechanism for screening services, disposition of
parents and healthcare professionals towards such pro-
grammes and areas where improvements are most indi-
cated.
Methods
Study design
This study was designed as a cross-sectional, descriptive
and questionnaire-based survey complemented by other
relevant reports on infant hearing loss in developing
countries in view of the wide variations in practices and
the lack of a standardised screening protocol across coun-
tries.
Survey instrument and themes
A structured questionnaire was designed to ascertain the
following information from each country surveyed [see
Additional file 1]:
• Type(s) of infant hearing screening models implemented (if
any)
• Financing mechanism for screening services
• Parental and health professionals' attitudes towards infant
hearing screening
• Achievements and challenges of infant hearing screening pro-
grammes
The questionnaire did not require the respondents' active
involvement in an infant hearing screening project but
their familiarity with the subject matter in their respective
countries.
Data collection
The survey instrument was sent via e-mail to a cross-sec-
tion of researchers and ear care specialists (physicians,
ENT surgeons and audiologists) resident in each of the
sub-regions that make up the developing world based on
UNICEF/World Bank classification namely: Sub-Saharan
Africa [SSA], Middle East/North Africa [MEN], South Asia
[SOA], East Asia/Pacific [EAP] and Latin America/Carib-
bean [LAC], excluding Central/Eastern Europe [CEE]. Tai-
wan and Hong Kong were considered independently of
mainland China to highlight the historical antecedents to
infant hearing screening in these locations.
Prospective respondents were identified from published
work in PubMed or in the public domain relating to hear-
ing impairment in developing countries. Those contacted
were informed of the purpose of the survey, which was to
gather up-to-date and representative information on
activities relating to early hearing detection and interven-
tion in the developing world. The target was to enlist at
least two countries to represent each sub-region. In order
to make up for the lack of response from a particular
region, we relied on published articles from the region.
Moreover, responses obtained from the survey were sup-
plemented with information from relevant articles in
Medline/PubMed (1996 – 2006), abstracts of presenta-
tions at the biennial international conference on newborn
hearing screening NHS2006 at Lake Como, Italy [30] and
an electronic search of the internet. The PubMed search
was backdated to 1996 to ascertain the progress after the
1995 WHA resolution. The NHS2006 was selected
because this biennial meeting is perhaps the largest and
the only international conference wholly dedicated to
newborn hearing screening outside the USA.
Criteria for evaluating performance of screening 
programmes
The conventional criteria for evaluating the performance
of an infant hearing screening programme in developedBMC Health Services Research 2007, 7:14 http://www.biomedcentral.com/1472-6963/7/14
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countries are often related to the following JCIH (2000)
benchmarks [31]:
• Screen should be offered to a minimum of 95% of eligible
infants before hospital discharge or within one month of age
[Screening Coverage]
• The referral rate following the screening process should not
exceed 4% [Screening Efficiency].
• The return-for-follow-up rate should not be less than 95% of
infants who failed the screening tests and were referred for
diagnostic evaluation [Return Rate]
• Diagnostic evaluation is provided for infants who failed the
screening tests before 3 months of age and enrolled in a family-
centred early intervention programme before 6 months of age
[Age of Diagnosis and Intervention].
There are presently no benchmarks for evaluating infant
hearing screening programmes in developing countries.
What constitutes "reasonable standards" would be
expected to reflect the realities and scope of possibilities in
this region. Nonetheless, valuable insights can still be
ascertained from evaluating the performance of pilot
screening programmes that have been documented based
on the JCIH criteria.
Data analysis
The emphasis in this descriptive study was on qualitative
analysis of available information from the questionnaire
and internet searches. The quantitative data relating to the
performance of screening programmes were obtained
from peer-reviewed publications (PubMed) or from
abstracts of presentations at the NHS2006 conference,
which may take up to 2 years before they become availa-
ble in PubMed when published. For ease of analysis, the
responses to the questionnaire on the attitudes of parents
and professionals towards newborn hearing screening
were structured on a Likert scale and scored as follows:
very negative (1), negative (2), not sure (3), positive (4),
and very positive (5).
Results
Sixteen (88.9%) of the 18 professionals contacted in
Kenya, Nigeria, South Africa [SSA], Oman, Saudi Arabia,
Iran [MEN], India, Pakistan, Nepal, Bangladesh [SOA],
China, Hong Kong, Taiwan, Malaysia, Philippines [EAP],
Brazil, Mexico and Chile [LAC] responded. They com-
prised two paediatricians, nine otolaryngologists and five
audiologists - typically reflecting the current multidiscipli-
nary intervention for infant hearing loss globally. No
responses were received from Kenya and Pakistan at the
time of this report. Nepal and Bangladesh were excluded
in the final analysis as the respondents reported that no
infant hearing screening programme had commenced in
these countries at the time of the survey despite substan-
tial presence of multilateral institutions and donor agen-
cies. Three more countries (Jordan, Qatar and Singapore)
and Pakistan were added to the list of countries based on
the results from our electronic searches of the internet and
PubMed making a total of 18 countries including Hong
Kong and Taiwan as shown in Table 1[32-49].
Demography of countries with infant hearing screening 
programmes
The demographic characteristics of these countries are pre-
sented in Table 1, excluding those for Hong Kong and Tai-
wan which are currently not provided by any of the UN
agencies [50]. The per capita income varies from US$390
in Nigeria to US$24,220 in Singapore. The World Bank
classifies countries with national income per capita less
than US$826 as low income; US$826 – US$10,065 as
middle income; and above US$10,065 as high income.
On this basis, Saudi Arabia, Qatar and Singapore are high
income developing countries with a good prospect of hav-
ing a standard of living and healthcare comparable to lev-
els in many developed countries. China and India are the
most populous countries and also have the highest
annual live births of 17.4 million and 26 million respec-
tively. In contrast, the annual live births are as low as
14,000 in Qatar, 40,000 in Singapore and 64,000 in
Oman. The majority of births in Nigeria, India and Paki-
stan occur outside regular hospital facilities (indexed by
the proportion of skilled attendants at birth) as displayed
in Figure 1. Infant mortality rate ranges from less than 20
per 1000 live births in Qatar, Oman, Malaysia, Singapore
and Chile to over 60 per 1000 live births in Nigeria, India
and Pakistan while life expectancy is lowest in Nigeria (43
years) and South Africa (47 years) compared with 79 years
in Singapore or 78 years in Chile. Private spending on
healthcare accounts for over half of national health
expenditure in all countries except Saudi Arabia, Qatar,
Oman and Malaysia. Government contributions to total
expenditure for healthcare services do not exceed 50% in
all the regions of the developing world (Figure 2) [51].
Private spending accounts for as high as 75% of total
health expenditure in South Asia and not less than 60% in
Sub-Saharan Africa in sharp contrast to the pattern in
developed countries (except USA) where public expendi-
ture accounts for over 70% of total health expenditure
(Figure 3). Private spending could be through private
health insurance, employer funding or out-of-pocket
expenditure. Out-of-pocket spending is the direct con-
sumer financial contribution to health care by individuals
after deducting health insurance, employer funding and
other private payments for health care. It accounts for the
bulk of private health expenditure in all regions of the
developing world.B
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Table 1: Demographic characteristics of countries with infant hearing screening programmes
REGION/
COUNTRY
Per Capita 
Income (US$)
Total Population 
('000)
Under 5 
Population ('000)
Annual Live 
Births ('000)
Born in 
Hospitals (%)
Born Outside 
Hospitals (%)
Infant Mortality 
('000)
Life 
Expectancy 
(Years)
Total Health 
Expenditure (2003)
% Public % Private
Sub Sahara Africa 
[SSA]
Nigeria 390 128,709 21,943 5,323 35 65 101 43 26 74
South Africa 3,630 47,208 5,248 1,093 84 16 54 47 39 61
South of Asia 
[SOA]
India 620 1,087,127 120,155 26,000 43 57 62 64 25 75
Pakistan 600 154,794 20,922 4,729 24 76 80 63 28 72
Middle East 
[MEN]
Saudi Arabia 10,430 23,950 3,178 665 91 9 21 72 76 24
Iran 2,300 68,803 5,890 972 90 10 32 71 47 53
Qatar 12,000 777 85 14 99 1 18 73 74 26
Jordan 2,140 5,561 734 150 100 0 23 72 45 55
Oman 7,830 2,534 302 64 95 5 10 74 83 17
East Asia Pacific 
[EAP]
China 1,290 1,307,989 86,055 17,372 96 4 26 72 36 64
Malaysia 4,650 24,894 2,38 549 97 3 10 73 58 42
Philippines 1,170 81,617 9,873 2,028 60 40 26 71 44 56
Singapore 24,220 4,273 226 40 100 0 3 79 36 64
Latin America 
[LAC]
Brazil 3,090 183,913 17,946 3,728 96 4 34 71 45 55
Mexico 6,770 105,699 10,982 2,201 95 5 23 75 46 54
Chile 4,910 16,124 1,246 249 100 0 8 78 49 51
Sources: UNICEF State of the World's Children 2006; WHO World Health Report 2006BMC Health Services Research 2007, 7:14 http://www.biomedcentral.com/1472-6963/7/14
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Profile of infant hearing screening projects
The earliest reported project using electrophysiological
tests of all the 18 countries identified was perhaps initi-
ated in India in 1986 among high risk infants, based on
the responses to the questionnaire survey (Table 2). As
with all the countries surveyed, services are concentrated
in urban areas presumably because of accessibility to
available audiological services. The second oldest screen-
ing programme is in Brazil and dates back to 1988. There
are over 237 screening sites across many states in this
country and the programme is by far the largest in any
developing country. In Oman universal newborn hearing
screening is currently offered routinely nationwide after
prior pilot studies in various regions of the country. This
is perhaps the first developing country with a national
programme on newborn hearing screening. Chile has just
implemented a national initiative to screen almost half of
the babies born in the country based on known risk fac-
tors for hearing loss. In Iran, pilot studies have also been
conducted in 28 of its 30 provinces [36].
Overall, screening protocols consist of both universal and
targeted approaches in which OAE and/or AABR tech-
niques are employed. The targeted screening is commonly
based on the risk factors recommended by the JCIH [31].
The majority of screening programmes are hospital-based
except in Nigeria, South Africa, Taiwan and Hong Kong
(and to a limited extent in China, Jordan and Oman)
where community-based programmes have been
reported. Community-based programmes are typically
implemented during routine immunisation clinics at
community health centres [32,33,41].
Existing healthcare personnel in hospital-based projects
are more commonly entrusted with screening except in a
few countries like Nigeria where non-specialists are
recruited and specially trained to conduct screening.
Screening in hospitals is predominantly handled by
nurses, audiologists or otolaryngologists but diagnostic
tests are conducted by audiologists or otolaryngologists.
Community-based programmes are more commonly
handled by non-specialists who have received training in
the use of screening instruments. However, the screening
Health expenditure patterns in developed countries Figure 3
Health expenditure patterns in developed countries.
 
            
0
10
20
30
40
50
60
70
80
90
100
USA Australia Canada France Germany Japan UK
Countries
%
 
o
f
 
T
o
t
a
l
 
H
e
a
l
t
h
 
E
x
p
e
n
d
i
t
u
r
e
Public Private  Out-of-Pocket 
 
  Data Source: WHO World Health Report 2006 [60] 
Proportion of births outside hospital facilities Figure 1
Proportion of births outside hospital facilities.
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Health expenditure patterns in developing regions Figure 2
Health expenditure patterns in developing regions. Latin 
America & the Caribbean [LAC], Middle East & North 
Africa [MEN], Sub-Saharan Africa [SSA], East Asia & Pacific 
[EAP], South of Asia [SOA]
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) Table 2: Profile of infant screening programmes in developing countries
REGION/Country 
[Related reference(s)]
Data Source(s) Year; (Location) Model Protocol Government 
Funding
Patient 
Obligation
Support 
Programme
Sub Sahara Africa
Nigeria [32] Survey, PubMed 2005 (Lagos) Hospital, MCC (UNHS) OAE AABR None None None
South Africa [33] Survey, PubMed 2003 (Pretoria) Hospital, MCC: TNHS OAE None None None
South of Asia
India [http://healthlibrary.com] Survey, Internet 
NHS2006
1986 (Mysore, Kochi, Chennai) Hospital: TNHS OAE Screening Diagnosis; 
Hearing aids
Pre School & 
School Entry
Pakistan [34] Internet 1999 (Lahore) Hospital: UNHS OAE N/A N/A N/A
Middle East
Saudi Arabia [35] Survey, PubMed 1996 (Jeddah) Hospital: UNHS OAE None All Services School Entry
Iran [36] Survey, NHS 2006 2002 (Tehran, Mashad) Hospital: UNHS OAE None All services Pre School
Qatar [37] NHS2006 PubMed 2003 (Doha) Hospital: UNHS OAE Screening, Diagnosis N/A N/A
Jordan [38] PubMed 2001 (Multiple Cities) Hospital, MCC: UNHS OAE Minimal N/A N/A
Oman [39] Survey, PubMed 2001 (Multiple cities) Hospital, MCC: UNHS OAE, AABR Screening, Diagnosis None School Entry
East Asia Pacific
China [40] Survey, NHS2006 
PubMed
1999 (Shanghai, Beijing, Shandong) Hospital MCC : TNHS UNHS OAE AABR Education Materials Screening 
Diagnosis
Pre-School
Hong Kong [41] Survey, PubMed 1998 (Hong Kong Hospital, MCC TNHS, UNHS OAE AABR Screening Diagnosis; 
Hearing aid
Pre-School & Sch 
Entry
Taiwan [42,43] Survey, PubMed 1998 (Taipei) Hospital: UNHS OAE, AABR No All Services Pre-School
Malaysia [44] Survey, PubMed 2000 (Kuala Lumpur) Hospital: UNHS OAE Screening, Diagnosis Hearing aids Pre-School & Sch 
Entry
Philippines [45] Survey PubMed 2000 (Manila) Hospital: UNHS OAE None All services None
Singapore [46,47] PubMed NHS2006 2002 (Singapore) Hospital: UNHS AABR OAE None* All services N/A
Latin America 
Brazil [48] Survey, PubMed 1998 (Multi cities) Hospital: TNHS, UNHS OAE No All Services Pre-School & 
School Entry
Mexico [49] Survey, PubMed 2005 (MexicoCity) Hospital: TNHS, UNHS OAE AABR Screening Diagnosis; 
Hearing aid
School Entry
Chile [http://www.med.uchile.cl] Survey, Internet 2005 (National) Hospital TNHS OAE AABR Full None School Entry
N/A: Not Available *After the initial pilot studies; OAE: Oto-acoustic emissions; AABR: Automated Auditory Brainstem Response MCC: Maternal & Child Health Centre; TNHS: Targeted Newborn Hearing 
Screening; UNHS: Universal Newborn Hearing ScreeningBMC Health Services Research 2007, 7:14 http://www.biomedcentral.com/1472-6963/7/14
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staff rely on the existing primary healthcare workers in
educating parents on the value of the programme.
Funding strategies for infant hearing screening services
Most of the pilot projects were privately initiated by
researchers and services were offered in public and private
hospitals. For programmes implemented in public hospi-
tals government funding, if available, was usually limited
to providing free screening or for public awareness cam-
paigns/materials (Table 2). Data from most of the middle-
to-high income countries were scanty and it is most likely
that public funding in many of these countries may
extend to free diagnostic tests and provision of hearing
aids. For instance, a 4-year pilot UNHS programme in Sin-
gapore and the emerging national programmes in Chile
and Oman are also publicly funded [39,46]. In Nigeria,
the UNHS pilot studies at five locations have been funded
through a combination of public and private sources
including donation or loan of equipment by manufactur-
ers. The programme in Nigeria is currently offered at no
charge to parents up to the provision of hearing aids
through funding support from a local non-governmental
organisation. In Brazil, private hospitals may charge
between US$25 and US$40 to screen a baby. The cost of
screening a baby was generally not reported in most stud-
ies and would normally be expected to depend on several
factors like the type of equipment used, the model of
screening, the level and calibre of personnel conducting
the programme and other overhead expenses. In Oman,
the cost of screening a baby was estimated as US$7.10.
There was no evidence that any of the countries in this
review had a national health insurance scheme incorpo-
rating hearing screening services, which may indicate that
private contributions to health expenditure were predom-
inantly derived from out-of-pocket spending by individ-
ual health seekers. In addition, it was difficult to establish
the cost of post-screening services such as diagnostic tests
and fitting of hearing aids. The costs of cochlear implants
were reported to vary from US$25,000 to US$30,000 in
South Africa but similar information was not readily avail-
able in countries such as Brazil, Mexico, Iran, India and
China where they are also currently offered.
Parental and healthcare professionals' attitudes towards 
infant hearing screening
Parental attitude was reported to be generally positive
based on the responses to the survey, except in India
where it was rated as uncertain (Figure 4). However,
parental opposition has not been reported in the few
infant hearing screening projects that have been under-
taken so far in India or in any other developing country.
Parental attitude was rated as most positive in Nigeria.
Similarly, the attitudes of health professionals were
mostly rated as positive except in South Africa and Malay-
sia where some ambivalence has been noted. Professional
support appears to be most enthusiastic in Mexico. The
attitudes of parents and health professionals were rated
equally in Hong Kong, Taiwan, Malaysia, Saudi Arabia
and Brazil. It is pertinent to observe that these attitudinal
ratings are principally based on anecdotal evidence rather
than systematic investigation of parents and profession-
als. Only very limited published data exist on the current
knowledge and attitude of health professionals towards
hearing screening in developing countries. Evidence from
the limited information obtained from parents who have
participated in screening programmes or parents of hear-
ing impaired children generally indicate that infant hear-
ing screening is highly desirable [52,53]. One UNICEF-
supported study in Iran intended to establish the knowl-
edge, attitudes and practices of parents of children with
various disabilities found that 73% of parents of deaf chil-
dren had a favourable attitude and 72% had "correct
knowledge" [54]. However, another study among families
of babies 4 months or less attending immunisation clinics
in Singapore reported that 59% of those whose babies had
missed hearing screening at birth refused the offer of
screening at the immunisation clinics because they
doubted their babies had a hearing loss, or that they felt
parents can monitor the babies hearing themselves or that
they needed to wait till the baby is older [46].
Performance of infant hearing screening programmes
Table 3 shows the available published data from a cross-
section of countries. Pilot studies based on target screen-
ing are not considered because of the lack of uniform per-
formance criteria for such programmes.
Attitudes of parents and health professionals towards infant  hearing screening [Key: Very negative (1); Negative (2); Not  sure (3); Positive (4); Very positive (5)] Figure 4
Attitudes of parents and health professionals towards infant 
hearing screening [Key: Very negative (1); Negative (2); Not 
sure (3); Positive (4); Very positive (5)]
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Table 3: Performance of universal infant screening pilot programmes in developing countries
Region/Country 
[Reference]
No of Births or 
Eligible Infants
Total Screened 
(% Coverage)
Referral at 
Discharge (%)
Returned for 
Follow-up (%)
Referred for 
Diagnosis
Returned for 
Diagnosis (%)
Mean Age of 
Diagnosis (months)
Sub Saharan Africa
Nigeria [32] 1,132 1,132 (100) 204 (18.0) 116 (56.9) 57 32 (56.0)* 2.0*
South Africa [33] 510 489 (95.9) 68 (13.9) 27 (39.7) 9 1 (11.1) 6.0*
South of Asia
Pakistan [34] n/a 756 77 (10.2) 26 (33.8) 6 6 (100) 6.0
Middle East
Saudi Arabia [35] 13,071 11,986 (91.7) 300 (2.5) 300 (100) 22 22(100) 5.5
Oman [39] 32, 080 21,387 (66.7) 262 (1.2) 262 (100) 55 36 (65.5) n/a
East Asia Pacific
Hong Kong [52] 1,076 1,064 (98.9) 476 (44.7) n/a 37 35 (94.6) n/a
Taiwan [42] 7 7,496 6,765 (90.2) 430 (6.4) 370 (86.0) 154 140 (90.9) 3.5
Malaysia [44] 5,242 4,437 (84.6) 531 (12.0) 303 (57.0) 55 34 (61.8) 3.6
Singapore [47] 44, 579 44,488 (99.8) 1040 (2.3) 940 (90.4) 254 194 (76.4) 2.7
Latin America
Brazil [48] 4,631 4,196 (90.6) 73 (1.7) 60 (82.2) 25 25 (100) 4.3
Mexico [49] 3,069 3,066 (99.9) 33 (1.1) 32 (97.0) 7 7 (100) 3.0
*unpublished
n/a not availableBMC Health Services Research 2007, 7:14 http://www.biomedcentral.com/1472-6963/7/14
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The lowest screening coverage of 66.7% was reported in
Oman and is largely attributable to the inception of a
nation-wide screening programme rather than a pilot
study. The recommended target of 95% coverage was
achieved in Nigeria, South Africa, Hong Kong, Singapore
and Mexico. Singapore screened nearly all of its 44,579
eligible babies which was the highest number of babies
screened of all countries considered in this review. The
referral rate at discharge was lowest in Oman at 1.2% and
highest in one Hong Kong pilot study, at 44.7%. The latter
is attributable to the pilot screening protocol which
required all babies to undergo three stages of test with
OAE [52]. The referral rates in Saudi Arabia, Oman and
Brazil fell within the recommended target of 4% or less.
The "referral rate prior to discharge" was preferred to elim-
inate the differences in the number of repeat tests across
various protocols. The rate of "returned-for-follow-up"
after discharge from the hospital or the screening centre is
an index of how effective the tracking system is as well as
the voluntary disposition towards the completion of the
screening by parents or the logistics of returning to the
screening centres. The lowest rate of 39.7% was recorded
in South Africa where the screening programme was
implemented during routine visits for immunisation. The
recommended target of a minimum of 95% was only
attained in Saudi Arabia and Oman. The rates for Taiwan
(86.0%) and Brazil (82.2%) are impressive for initial
stages of their programmes. Information on the age of
diagnosis and enrolment in family-centred intervention
services were rarely reported. Where available, age of diag-
nosis varied from 2.7 months in Singapore to 5.5 months
in Saudi Arabia [35,46]. In the absence of UNHS, age of
diagnosis varies from about 18 to 86 months [55,56].
Discussion
In an earlier report on the feasibility of infant hearing
screening in developing countries a number of challenges
were identified that may impede the implementation of
such a programme [57]. But it was equally noted that
these challenges were not insurmountable given the vari-
ety of options available at different levels of healthcare
delivery. Notwithstanding the myriad constraints in
developing countries, our current report demonstrates
that early hearing detection programmes are feasible as a
public health initiative and are required to facilitate the
systematic development of requisite services and the
implementation of WHA 48.9 resolution [5].
Screening models and platforms
The screening models that have been implemented so far
range from the most basic of targeting high risk infants for
screening to universal screening with OAE and/or AABR.
Cost considerations significantly influence the choice of
screening protocol as do the logistics of achieving effective
coverage and screening performance. The use of non-spe-
cialists as screeners at primary healthcare level has been
found to be cost-effective while regular health workers are
effective in educating parents on the programme. Restrict-
ing screening to highly skilled personnel like audiologists
or other ear care specialists may not serve the course of a
rapid spread of infant hearing screening as an important
public health programme due to the general dearth of
such manpower. Experiences from countries like Nigeria
and India also suggest that depending on primary care
physicians to refer high-risk babies to a central location
for screening is ineffective. Hospital-based screening pro-
grammes are essential in all countries but it is also neces-
sary to have complementary community-based
programmes especially in countries where a significant
proportion of births occur outside hospitals. Most com-
munity-based programmes are linked to visits to maternal
and child clinics for routine immunisation in the first
three months of life. In India, incorporating infant hear-
ing screening into the country's Integrated Child Develop-
ment Services (ICDS) has been considered as a feasible
option. The ICDS is reputed as the world's largest commu-
nity-based outreach programme with over 40,000 centres
nationwide [58]. It reaches more than 34 million children
aged 0–6 years and 7 million pregnant and nursing moth-
ers. However, screening babies older than 3 months in
community-based programmes could be difficult as they
may be too restless to be tested with OAE or AABR without
sedation. Moreover, finding suitable test environments
especially in busy hospitals or community health centres
may also present some challenges that must be managed
creatively across potential locations. Tolerance limits of
screening equipment for ambient noise, durability of con-
sumables, access to timely technical support and availa-
bility of loanable equipment when instruments are sent
for maintenance/repairs should not be overlooked in the
choice of equipment manufacturers. Although cost-effec-
tiveness analysis data are not currently available from
developing countries, it may be useful to consider targeted
screening as a possible take-off point where cost is a major
hurdle. For instance, prevailing adverse perinatal events
that account for high infant mortality in some countries
have been associated with permanent hearing impairment
[7]. Since some of these factors can be readily ascertained
even from parents they may serve as useful criteria for ini-
tiating community-based targeted screening. However,
pilot programmes based on universal infant hearing
screening provide more useful information for planning
purposes and for establishing vital epidemiological data
like the incidence of and/or risk factors for hearing
impairment more accurately.
Funding issues
The costs of acquiring and maintaining screening equip-
ment at community levels could be a major concern for
the rapid expansion of programmes. Typical OAE screen-BMC Health Services Research 2007, 7:14 http://www.biomedcentral.com/1472-6963/7/14
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ers cost about US$3,000 and AABR about US$8,000
excluding consumables and replacement parts. To ensure
that screening is uninterrupted at least two of such screen-
ers would be required even at the least busy birthing cen-
tres and many more would be required if the screening
protocol combines both OAE and AABR.
Most of the concerns often expressed in relation to fund-
ing arise from misconceptions about the current role of
government in healthcare financing in developing coun-
tries [59]. Government contributions to national health
expenditure in developed countries range from an average
of 80% in Europe, 81% in Japan, 70% in Canada, 68% in
Australia to 45% in USA [60]. This contrasts sharply with
the levels in developing countries where government con-
tributions rarely exceed 50% and are as low as 25% in
India and 26% in Nigeria. Although private health
expenditure accounts for 55% of the total expenditure in
USA, only 24% of this amount is attributed to out-of-
pocket spending – in sharp contrast to India or Nigeria
where out-of-pocket spending accounts for at least 90% of
private health expenditure. In effect, out-of-pocket spend-
ing accounts for about 13% of expenditure in USA or 10%
in Europe compared with 75% in India or 76% in Nigeria.
These data would suggest that it may be unethical to pred-
icate the decision for introducing new health interven-
tions in most developing countries solely on government
financial capacity if the consumers ultimately will pay for
the services. The way individuals choose to order their
spending priorities is often unpredictable and complex.
For instance, some communities may consider socially
stigmatised diseases more important than non-stigma-
tised diseases even if they are less prevalent [61]. The scar-
city of public funding in some of the countries perceived
as poorly-resourced should therefore not constitute a
deterrent to the systematic development of infant hearing
screening services in these countries.
Governments in low and middle income countries are
unlikely to ever have adequate resources to cater for all the
myriad healthcare needs of their citizens. It is more plau-
sible to see the role of government as facilitators of public-
private partnerships in which its preoccupation will be
towards creating public awareness and setting standards
for best practices rather than the direct provision of serv-
ices especially for non-fatal chronic conditions. This role
should also extend to ensuring that training curricula of
health professionals provide up-to-date skills for the
broad spectrum of prevailing healthcare needs. Multilat-
eral institutions such as the World Bank, UNICEF, WHO
and their funding partners can play a valuable role in pro-
viding financial and relevant technical expertise to sup-
port pilot studies. Such studies have been known to be
successful if they are preceded by the inclusion of goal(s)
for early hearing detection and intervention in the
national health policy [32,62]. All these initiatives will
have a good chance of success if they are implemented
within the stepwise framework recently articulated by
WHO [63]. It is also pertinent to acknowledge current
efforts by WHO and other organisations towards the pro-
vision of guidelines for audiological services as well as the
development of low-cost solar powered hearing aids cost-
ing no more than US$40 per piece compared to about
US$500 dollars in developed countries [64]. Collabora-
tive initiatives at the global level between multilateral
institutions, their donor partners and manufacturers
towards making screening equipment and the associated
costs more affordable would also be desirable. Having
one diagnostic centre in a district/province serving several
hospitals that only conduct screening as has been success-
fully implemented in China may prove to be cost-effective
[65]. But this approach would have to be balanced with
the risk of poor follow-up rate in some other countries. Of
the 2 to 6 per 1000 babies with neonatal hearing loss in
developing countries [8], those with severe-to-profound
hearing loss that require hearing devices may not exceed 2
per 1000. Many communities can still mobilise resources
to provide support for those in need as the devices
become cheaper through concerted global initiatives.
Notable charitable organisations like Christoffel-Bliden-
mission, Lions Club and Rotary International already
have networks for supporting individuals with hearing
impairment in many developing countries which can also
be channelled towards early hearing detection services.
Parental and professional support
The attitude of parents also has as much impact in opti-
mising the uptake of screening services as the support of
health professionals like nurses and physicians. Initial
enthusiasm for screening before hospital discharge may
be short-lived due to poor parental education on the value
of screening resulting in poor follow-up compliance. Sus-
taining physician support in environments overwhelm-
ingly oriented towards treating fatal diseases is a major
challenge but can be mitigated by government support
through on-going public awareness campaigns on the
value and efficacy of early detection and intervention
[66,67]. Experiences from developed countries would sug-
gest that there are no quick-fixes especially at the early
stages of infant hearing screening programmes. Success
stories for early intervention are still quite limited while
the role of family involvement in the habilitation process
is not yet widely appreciated. Another crucial area of sup-
port required from government relates to cultural reorien-
tation in communities where current beliefs and attitudes
are detrimental to effective parental acceptance of infant
hearing screening [15-17,68].
Parents must be sufficiently educated on the benefits and
risks of the screening process and their consent subse-BMC Health Services Research 2007, 7:14 http://www.biomedcentral.com/1472-6963/7/14
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quently sought prior to conducting the test(s). Every preg-
nant mother expects and longs to give birth to a healthy
baby and to leave the birthing centre with the assurance
that their apparently well child has every chance for opti-
mal development. Parental consent for screening can
therefore be readily obtained if it is presented as part of
routine neonatal examinations after delivery and because
the screening procedure itself is painless, non-invasive
and quick to administer. However, the health professional
must handle the screening process with sensitivity because
the arrival of a newborn is an event that is both joyous and
emotion-laden for the parents. The most opportune time
to begin discussion with parents is probably during ante-
natal clinics or sometime before delivery.
Balancing the benefits of screening against its potential
harms may leave health professionals with an ethical
dilemma because no screening test is perfect. The risks of
false assurance that a child has no hearing loss or of
unnecessary anxiety for a child falsely detected with hear-
ing loss when in fact the opposite is the case must not be
ignored. Practical ways of minimising these risks include
delaying screening beyond 48 hours after birth to elimi-
nate the effect of vernix plugs, conducting a two-stage
screening with OAE and AABR and minimising the effect
of ambient noise during screening, which could be quite
a daunting challenge in busy neighbourhoods.
Programme performance
The impressive coverage from all the screening projects is
a strong indication of the high parental acceptance and
encouraging support from health professionals. This is
not to suggest that difficulties are not occasionally
encountered in the course of securing optimum screening
up-take. For instance, in Malaysia, the relatively lower
coverage was attributed to the challenge of getting nurses
involved with screening to effectively combine this func-
tion with their other regular duties which are often
regarded as more important. In other countries, babies
may be discharged before screening because parents are
reluctant to wait or the screening facilities cannot cope
with the number of babies eligible for screening before
discharge. In such circumstances it has been found useful
to encourage parents to ensure that their babies are tested
during post-natal visits for immunisation to the hospital
or community health centres.
High referral rates are common in the initial stages of the
screening programme and they improve as the screening
teams become more experienced. However, some screen-
ing protocols are readily associated with high referral rates
especially when screening is limited to only OAE even
with multiple testing. AABR instruments may not be
affordable and this may account for its exclusion in some
locations. Referral rates are usually minimal when OAE
and AABR are combined. Service providers would need to
make their own judgment on the most desirable trade-off
between cost and efficiency especially where certain cate-
gories of hearing impairment like auditory neuropathy
may be missed in screening programmes solely based on
OAE.
Ensuring that parents of babies who failed the screening
test prior to discharge return for subsequent follow-up
appointments is a major problem in most countries. Dur-
ing the initial screening maternal consent may be occa-
sioned by mothers simply not wanting to feel left-out
since the majority of mothers are likely to consent. Return
for follow-up may therefore serve as a more accurate index
of parental commitment than the coverage achieved for
the initial screening. Factors such as transportation costs,
parental convenience and anxiety may contribute to a
high default rate for follow-up. Parents of children with
severe-to-profound hearing loss are sometimes more
cooperative when requested to attend follow-up appoint-
ments if their babies were tested later than 3 months of
age as they may have already begun to suspect the child's
hearing difficulty. On some occasions poor return rates
are associated with the lack of an effective tracking system
or poor communication between health professionals
and the parents. These difficulties have also been reported
in developed countries and programmes have demon-
strated increasing efficiency after implementing improved
tracking systems and increasing awareness of hearing loss
amongst healthcare professionals and families [69].
Where cost is a major deterrent, it may be useful to con-
sider possible ways of supporting parents such as waiving
charges for follow-up services including diagnostic evalu-
ations since the number of babies are likely to be low at
this stage in a well-conducted programme.
The limitations that may be associated with this study
include the fact that the methodology may not fully rep-
resent the current status of early hearing detection and
intervention in some countries due to the lack of recent
data in the public domain. Similarly, many countries that
have initiated infant screening projects may have been
omitted. In addition, relying on a single respondent to the
questionnaire-survey for each country could have limited
the coverage especially in very large countries like India
and Brazil. Valuable information for some Latin American
countries like Chile or a populous country like China may
also not be published in English which restrict their usage
for our study. However, the insights from this progress
report should serve as baseline data for a more extensive
future audit. The lack of published data in many countries
is not in itself an evidence of a lack of progress but an indi-
cation of the prevailing challenges to the conduct and
reporting of epidemiological research in the developing
world.BMC Health Services Research 2007, 7:14 http://www.biomedcentral.com/1472-6963/7/14
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Conclusion
This report demonstrates that infant hearing screening is a
feasible and viable early hearing detection strategy in
developing countries. The nationwide implementation of
such programmes may be hampered in many countries by
low public awareness, resource constraints and lack of
government and donor support. However, it is worth not-
ing that no public health intervention is without chal-
lenges and those related to infant hearing screening may
be daunting but not insurmountable. The most successful
public health programmes often start from small begin-
nings and are followed by systematic scaling up. Universal
newborn hearing screening has been mandated in many
developed countries not because there were adequate sup-
port services in all communities or full support from all
health professionals at inception but rather in recognition
of the overriding value of early detection and the incen-
tives it provides for the systematic scaling up of services to
meet emerging and growing needs. Evidence from a rap-
idly expanding number of countries such as Brazil, Oman
and Chile that have progressed from rudimentary pilot
projects to multi-city programmes lend credence to infant
hearing screening as an important and achievable public
health initiative in the developing world. So also are the
many pilot projects that have been sustained since their
inception without public funding. These voluntary initia-
tives are valuable in providing essential data for the plan-
ning and systematic development of relevant services
towards the effective delivery of an important public
healthcare service in developing countries.
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